LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
Clinical trials for LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to control tough skin cancer without surgery
Disease control OngoingThis study tests whether combining radiation therapy with the immunotherapy drug cemiplimab can help people with advanced skin cancer (squamous cell carcinoma) that cannot be surgically removed. About 34 participants will receive this treatment to see how long the cancer stays un…
Matched conditions: LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 10:28 UTC
-
New hope for transplant patients with advanced skin cancer: RP1 trial launches
Disease control OngoingThis study tests a drug called RP1, which is injected directly into skin tumors, for people who have had an organ or stem cell transplant and now have advanced skin cancer. The goal is to see if RP1 can shrink tumors safely without harming the transplanted organ. About 69 partici…
Matched conditions: LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC